跳转至

Handling Abnormal Test Results: Grey Zone, False Positives/Negatives and the Review Workflow

Key takeaway: Abnormal test results — grey zone, false positive, false negative, or a result that disagrees with the clinical picture — are not frightening in themselves; what is frightening is "not reviewing, not investigating, and acting rashly". There is a standard sequence for handling an abnormal result: first check whether the controls are normal, then identify the type of anomaly (grey zone / false positive / false negative), work through the possible causes, and finally retest or cross-verify. A single abnormal result is only a signal to be investigated, not a final conclusion.

Molecular testing is very accurate, but it is not "zero error". When a report shows a weak-positive grey zone, disagrees with the clinical picture, or is suspected of being a false positive or false negative, how should you handle it so that nothing is misjudged? This article sets out a systematic framework for handling abnormal test results. Reading an abnormal result presupposes being able to read a normal one, so start with Ct value interpretation.

Defining and handling weak-positive / grey-zone results

The "grey zone" is the borderline range between negative and positive, usually meaning a Ct value between 35 and 40. It may be a low-load infection, a sampling error or a non-specific signal, so it deserves the greatest caution:

Ct range Nature of the result Recommended handling
Ct < 35 Clear positive Act according to the load category
35 ≤ Ct ≤ 40 Weak positive (grey zone) Retest after 3–5 days, or cross-verify with another target
Ct > 40 / no signal Negative Confirm with the internal control whether it is a true negative

The principle for the grey zone is "retest rather than assume": do not ignore it because it is "weak" (it may be an early infection), and do not over-react because it is "positive" (it may be contamination or error). When retesting, resample rather than reusing the old sample, so that chance in the sampling step is ruled out.

The causes of false positives and false negatives examined

"False positive" and "false negative" are the two typical forms of abnormal results, and their causes are entirely different:

  • False positive: actually negative but measured as positive. The core mechanism is contamination — amplicon aerosols, cross-contamination between samples, reagent contamination and shared consumables can all carry "someone else's nucleic acid" into the reaction tube; see the contamination control section in laboratory biosafety.
  • False negative: actually positive but measured as negative. The core mechanism is "nothing was detected" — sampling that misses the lesion, a disease course that is too early or too late, nucleic acid degradation, residual extraction inhibitors or expired reagents can all make the target nucleic acid "absent" or "unable to amplify".

The key tools for telling the two apart are controls and the internal control: a falsely positive negative control points to contamination (false-positive risk); a negative target together with a negative internal control points to an extraction or amplification failure (false-negative risk). This is precisely the value of the internal control and control design described in laboratory quality control.

Abnormal-result troubleshooting table

Facing an abnormal result, working item by item through "phenomenon → possible cause → troubleshooting action" is the most efficient path:

Anomaly Possible cause Troubleshooting action
Negative control falsely positive Aerosol contamination, reagent contamination, shared consumables Stop testing, decontaminate nucleic acid, replace reagents and consumables
Positive control not positive Expired reagent, wrong program selected, template omitted Check reagent lot number and expiry, verify the program, remake the reaction mix
No internal control signal Extraction failure, residual inhibitors, nucleic acid degradation Re-extract, optimise sample handling, change storage conditions
Single sample in the grey zone Low-load infection, sampling error, non-specific signal Resample and retest, cross-verify with another target
Several anomalies in one batch Systematic contamination, reagent lot problem, instrument fault Discard the batch, trace the contamination source, verify the instrument
Result disagrees with clinical findings Wrong sampling timing, pathogen not covered by the test panel Check panel coverage, resample at a different time/site, add further tests

💡 Golden rule of troubleshooting: look at the controls first, then the internal control, and only then the sample. Abnormal controls mean discard the batch; an abnormal internal control points to the extraction step; only when both are normal is it worth suspecting the sample itself.

The result review workflow (in practice)

Building a standardised review workflow prevents "emotional handling". Follow these steps:

  1. Confirm the controls: check that the positive and negative controls of this batch are normal; if not, retest the whole batch;
  2. Check the information: confirm that the sample numbers, sample types and submission details match, ruling out mix-ups;
  3. Identify the type: decide whether this is a grey zone, a suspected false positive or a suspected false negative;
  4. Troubleshoot by the table: work through the "abnormal-result troubleshooting table" item by item to locate the cause;
  5. Verify by retesting: resample and retest, or cross-verify with a second target or method;
  6. Record everything: keep the troubleshooting process and the retest results so that they remain traceable;
  7. Conclude prudently: combine the retest results with the clinical information, and consult a veterinarian or the laboratory's technical team when necessary.

What to do when the result disagrees with the clinical picture

"The report says negative but the pigeon is clearly ill", or "the report says positive but the pigeon is bouncing around" — these are the scenarios that confuse fanciers most. The approach is as follows:

  1. Do not dismiss either side: testing has its limits (sampling, timing, panel coverage) and the clinical picture has its value (symptoms, course, epidemiology); the two complement rather than oppose each other;
  2. Check the test panel: confirm whether the pathogens tested cover the suspected pathogen, and add tests or widen screening if necessary;
  3. Adjust sampling: resample at a different site and time — take an oropharyngeal swab for respiratory signs and a cloacal swab for digestive signs; see the full sampling and submission workflow;
  4. Look at the Ct value: a positive with a very high Ct value (low load) may be no more than carriage or residue during recovery, and may not be clinically meaningful;
  5. Respect clinical judgement: the final decision rests on the veterinarian's integrated assessment of clinical findings and laboratory results, with test results serving as supporting evidence.

💡 Tip: when a test result is abnormal, the safest course is "retest + consult". For professional review and interpretation, contact Sanshi Bio testing services.

Key points

  1. The grey zone (Ct 35–40) is a signal to be investigated, not a conclusion; the principle is "retest rather than assume".
  2. False positives are mostly caused by contamination (aerosols, cross-contamination, reagents); false negatives mostly by "nothing being detected" (sampling, timing, extraction, reagents).
  3. Controls and the internal control are the probes that locate the type of anomaly: abnormal controls point to contamination, an abnormal internal control points to extraction failure.
  4. Troubleshoot anomalies item by item through "phenomenon → cause → action", looking at the controls first, then the internal control, and finally the sample.
  5. When results disagree with the clinical picture, testing and clinical assessment are complementary rather than opposed, and the veterinarian's integrated judgement prevails.

Entity quick reference

Molecular testing terms (Chinese–English)

Chinese name English Meaning
实时荧光定量 PCR qPCR / Real-time PCR Amplifies and reads fluorescence simultaneously; qualitative + quantitative
Ct 值 Ct value (Cycle Threshold) The number of cycles needed for the fluorescence signal to reach the set threshold
引物 Primer A short nucleic acid fragment that specifically initiates amplification
探针 Probe A fluorescently labelled sequence used for specific detection
多重 PCR Multiplex PCR Detecting several targets in a single reaction
SYBR Green SYBR Green I dye A fluorescent dye that emits light after binding double-stranded DNA
TaqMan 探针 TaqMan probe Releases fluorescence after being cleaved by the 5'→3' exonuclease activity of Taq polymerase
扩增曲线 Amplification curve The curve of fluorescence signal against cycle number
熔解曲线 Melting curve A curve reflecting the Tm of the amplicon and indicating specificity
闭管检测 Closed-tube detection No need to open the tube after amplification; markedly reduces aerosol contamination
病毒载量 Viral load The relative or absolute amount of viral nucleic acid in a sample

FAQ

What should I do about a grey-zone Ct value?

A Ct of 35–40 falls in the grey zone and may be a low-load infection, a sampling error or a non-specific signal. Resample and retest after 3–5 days, or cross-verify with a second target; do not jump to conclusions. See Ct value interpretation for details.

The result is positive but the pigeon has no symptoms — what is going on?

Possible reasons include early or latent infection, residual nucleic acid during recovery, low-load carriage, or a false positive caused by contamination. Judge by combining the Ct value (how high the load is) with the retest result, and consult a veterinarian if necessary.

The result is negative but the pigeon is clearly ill — what should I do?

First confirm whether the test panel covers the suspected pathogen, then adjust the sampling site and timing and resample for retesting. A negative result should be read together with the internal control to decide whether it is a true negative, and beware of false negatives caused by sampling or extraction.

How do I tell whether a result is a false positive or a real infection?

Look at the negative control and the Ct value: a falsely positive negative control indicates contamination (a high false-positive risk); a positive sample with a high Ct value (low load) may be carriage or residue. Retesting plus cross-verification is the key to confirmation.

When does a whole batch have to be retested?

When the positive control is not positive, the negative control is falsely positive, or several anomalies appear within one batch, this points to systematic contamination or reagent or instrument problems; the whole batch should be discarded and retested, and results must not be picked over selectively.

Does reviewing a result require new sampling?

Resampling and retesting is recommended, especially for grey-zone results and suspected false negatives — retesting the old sample only verifies the testing step, whereas resampling also rules out chance in the sampling step.

How long does it take to handle an abnormal result?

Review usually means resampling, extraction, a run on the instrument and interpretation; the exact turnaround depends on the panel and the workflow. Contact the testing laboratory to confirm review turnaround times; see Sanshi Bio testing services.

References

This content is for general information only and is not a diagnosis or treatment recommendation. Consult your veterinarian or the Sanshi Bio technical team (WeChat 15612372623 / email [email protected]) for specific testing and control plans.